MEP37508A - Process for the preparation of mesylates of piperazine derivatives - Google Patents

Process for the preparation of mesylates of piperazine derivatives

Info

Publication number
MEP37508A
MEP37508A MEP-375/08A MEP37508A MEP37508A ME P37508 A MEP37508 A ME P37508A ME P37508 A MEP37508 A ME P37508A ME P37508 A MEP37508 A ME P37508A
Authority
ME
Montenegro
Prior art keywords
mesylates
preparation
piperazine derivatives
relates
piperazine
Prior art date
Application number
MEP-375/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Marcel P M Van Aar
Stefanus J Schouten
Jan Zorgdrager
Michiel C Heslinga
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of MEP37508A publication Critical patent/MEP37508A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MEP-375/08A 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives MEP37508A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Publications (1)

Publication Number Publication Date
MEP37508A true MEP37508A (en) 2011-02-10

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-375/08A MEP37508A (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Country Status (34)

Country Link
US (1) US7030241B2 (cs)
EP (1) EP1362040B1 (cs)
JP (1) JP4328528B2 (cs)
KR (2) KR101000733B1 (cs)
CN (1) CN1176079C (cs)
AR (1) AR034206A1 (cs)
AT (1) ATE284875T1 (cs)
AU (1) AU2002250962B2 (cs)
BG (1) BG66101B1 (cs)
BR (1) BR0205683A (cs)
CA (1) CA2422703C (cs)
CZ (1) CZ301780B6 (cs)
DE (1) DE60202261T2 (cs)
DK (1) DK1362040T3 (cs)
DZ (1) DZ3489A1 (cs)
ES (1) ES2230481T3 (cs)
HR (1) HRP20030610B1 (cs)
HU (1) HUP0400772A3 (cs)
IL (1) IL153509A (cs)
IS (1) IS2417B (cs)
ME (1) MEP37508A (cs)
MX (1) MXPA03002359A (cs)
MY (1) MY130687A (cs)
NO (1) NO324460B1 (cs)
NZ (1) NZ524632A (cs)
PL (1) PL208363B1 (cs)
PT (1) PT1362040E (cs)
RS (1) RS51126B (cs)
RU (1) RU2272036C2 (cs)
SI (1) SI1362040T1 (cs)
SK (1) SK286143B6 (cs)
UA (1) UA75390C2 (cs)
WO (1) WO2002066449A2 (cs)
ZA (1) ZA200301590B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
CA2661120A1 (en) 2006-08-31 2008-03-06 Solvay Pharmaceuticals B.V. Titration schedule for bifeprunox for treating schizophrenia and kits for use therein
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
JP2011511011A (ja) 2008-02-05 2011-04-07 ハーバー バイオサイエンシーズ,インコーポレイテッド 医薬的固体状態形態
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32935A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Polimorfos de pardoprunox

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE44528T1 (de) * 1984-12-21 1989-07-15 Duphar Int Res Arzneimittel mit antipsychotischer wirkung.
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd 5―トリフルオロメチル―2―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素6員環化合物の製造方法
GB9200293D0 (en) * 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
ATE340173T1 (de) * 1996-03-29 2006-10-15 Duphar Int Res Piperazin- und piperidin- derivate
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
PT1362040E (pt) 2005-05-31
KR20030077523A (ko) 2003-10-01
US7030241B2 (en) 2006-04-18
BG108090A (bg) 2004-12-30
SI1362040T1 (en) 2005-06-30
US20040077631A1 (en) 2004-04-22
IS6876A (is) 2003-07-17
KR101000733B1 (ko) 2010-12-14
IL153509A0 (en) 2003-07-06
RU2272036C2 (ru) 2006-03-20
KR100859106B1 (ko) 2008-09-18
HUP0400772A2 (hu) 2004-08-30
YU64403A (sh) 2006-05-25
DZ3489A1 (fr) 2002-08-29
ATE284875T1 (de) 2005-01-15
BR0205683A (pt) 2004-07-06
EP1362040B1 (en) 2004-12-15
BG66101B1 (bg) 2011-04-29
CA2422703A1 (en) 2002-08-29
JP2004518741A (ja) 2004-06-24
HRP20030610B1 (en) 2006-02-28
HRP20030610A2 (en) 2005-06-30
SK3092003A3 (en) 2003-09-11
PL369330A1 (en) 2005-04-18
NO20031754L (no) 2003-04-15
AR034206A1 (es) 2004-02-04
NO20031754D0 (no) 2003-04-15
UA75390C2 (en) 2006-04-17
IS2417B (is) 2008-10-15
HUP0400772A3 (en) 2008-02-28
RS51126B (sr) 2010-10-31
DK1362040T3 (da) 2005-01-24
DE60202261T2 (de) 2005-05-19
JP4328528B2 (ja) 2009-09-09
KR20080064206A (ko) 2008-07-08
CZ301780B6 (cs) 2010-06-23
SK286143B6 (sk) 2008-04-07
MY130687A (en) 2007-07-31
MXPA03002359A (es) 2003-06-30
DE60202261D1 (de) 2005-01-20
WO2002066449A2 (en) 2002-08-29
CN1176079C (zh) 2004-11-17
ES2230481T3 (es) 2005-05-01
PL208363B1 (pl) 2011-04-29
NZ524632A (en) 2004-03-26
EP1362040A2 (en) 2003-11-19
HK1059934A1 (en) 2004-07-23
CA2422703C (en) 2010-04-13
CN1463268A (zh) 2003-12-24
NO324460B1 (no) 2007-10-22
CZ2003697A3 (cs) 2003-06-18
IL153509A (en) 2007-12-03
AU2002250962B2 (en) 2006-08-24
WO2002066449A3 (en) 2002-10-24
ZA200301590B (en) 2004-02-05

Similar Documents

Publication Publication Date Title
MEP37508A (en) Process for the preparation of mesylates of piperazine derivatives
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
HUP0401982A2 (hu) Indolizinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
RS20050380A (en) 3-amino piperidine derivatives and methods of manufacture
NO20060219L (no) Forbindelser
DE69736704D1 (de) Piperazin- und piperidin- derivate
TNSN07006A1 (en) Novel heterocyclic compounds
HUP9801072A2 (hu) Szubsztituált 6-és 7-amino-tetrahidro-izokinolin-karbonsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
AU6785201A (en) Novel pyrazinone derivatives
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
NO934652D0 (no) Enzymatisk prosess for stereoselektiv fremstilling av heterobicyklisk alkoholenantiomer
MXPA04000978A (es) Procedimiento para la produccion de 4-amino-2,5-bisheterociclilquinazolinas.
DK1303514T3 (da) Fremgangsmåde til fremstilling af azacycloalkanoylaminothiazoler
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
GB0215392D0 (en) Chemical compounds
RS50085B (sr) Novi derivati morfolina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
EA200400469A1 (ru) Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции
EA200101209A1 (ru) Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их
MY139258A (en) Carbamoyl-type benzofuran derivatives
MXPA03012073A (es) Amidoderivados heterociclicos.
MY140442A (en) A new process for the preparation of epothilone derivatives
MY134563A (en) Process for preparing distamycin derivatives
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander
MXPA03002532A (es) Nuevos compuestos de indolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.